Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 27, 2015 3:47 AM ET


Company Overview of Heptares Therapeutics Ltd.

Key Executives for Heptares Therapeutics Ltd.

NameBoard RelationshipsTitleAge
Malcolm Weir Ph.D.6 RelationshipsFounder, Chief Executive Officer and Director--
Daniel Grau M.Phil.23 RelationshipsPresident of USA Operations47
Miles Congreve No RelationshipsHead of Chemistry--
Tim Tasker No RelationshipsChief Medical Officer and Vice President of Development61

Heptares Therapeutics Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John Edward Berriman BA, BSc MSc, MBA 56 RelationshipsLonza Biologics PLC66
Malcolm Weir Ph.D. 6 RelationshipsHeptares Therapeutics Ltd.--
Michael Steinmetz Ph.D. 128 RelationshipsClarus Ventures, LLC67
Anja König Ph.D. 35 RelationshipsNovartis Venture Funds--
David Brown Ph.D., FRSC 43 RelationshipsAmura Holdings Limited--
View All Board Members

Heptares Therapeutics Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Heptares Therapeutics Ltd. CEO Compensation
Industry Average


The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Heptares Therapeutics Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at